Welcome to Newomics - Innovation Integration

Newomics Inc., an early stage biotechnology company in the San Francisco Bay Area, commercializes innovative (New) and integrative (Omics) platforms and solutions for personalized healthcare.

 
 

Technologies



Mass spectrometry is the enabling technology for proteomics. To fully realize the enormous potential of lab-on-a-chip in proteomics.
Read More...

Products



Services



 
 

News & Events

  • 2016.05.18

    Newomics has been selected to exhibit and showcase its technologies in the “Innovation Zone” and present in the business forum at the 2016 BIO International Convention...
    Read more...


  • 2016.05.18

    Newomics will present its new platforms and solutions for mass spectrometry at the 64th Conference on Mass Spectrometry and Allied Topics...
    Read more...


  • 2016.05.02

    Newomics announces that it has been awarded an NIH SBIR Phase II grant totaling $1.5 million
    Read more...


  • 2016.04.19

    Newomics’ Biomonitoring Chip paper has been selected as one of the ES&T’s Best Papers of 2015 for environmental technology.
    Read more...


  • 2016.01.22

    Newomics announces that it has been awarded two NIH SBIR Phase II grants totaling $3.0 million.
    Read more...


  • 2015.06.08

    C&EN of the American Chemical Society highlighted our publication on microchip blood test.
    Read more...


  • 2015.05.22

    Newomics publishes a new platform and solution for biomonitoring in Environmental Science & Technology.
    Read more...


  • 2015.01.01

    Newomics announces that it has established a scientific advisory board (SAB).
    Read more...